Effect of type II endoleaks and antiplatelet therapy on abdominal aortic aneurysm shrinkage after endovascular repair Atsushi Aoki, MD, Takanori Suezawa, MD, Kenji Sangawa, MD, Mamoru Tago, MD Journal of Vascular Surgery Volume 54, Issue 4, Pages 947-951 (October 2011) DOI: 10.1016/j.jvs.2011.03.269 Copyright © 2011 Society for Vascular Surgery Terms and Conditions
Fig Aneurysm shrinkage at 7 days and 6 months after endovascular abdominal aortic aneurysm repair (EVAR) in patients with a type II endoleak who were receiving multiagent antiplatelet therapy (APT) (n = 3), patients with a type II endoleak who were not receiving APT (n = 11), patients without a type II endoleak who were receiving APT (n = 11), and patients without a type II endoleak who were not receiving APT (n = 32). Error bars represent mean ± SD. Journal of Vascular Surgery 2011 54, 947-951DOI: (10.1016/j.jvs.2011.03.269) Copyright © 2011 Society for Vascular Surgery Terms and Conditions